Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb - 53 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of January 14, 2025 is 55.74.
  • The all-time high Bristol Myers Squibb stock closing price was 73.93 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 61.08, which is 9.6% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 39.35, which is 29.4% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 49.77.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 56.3650 56.7900 57.1400 55.3600 55.7400 -1.45%
2024 48.7208 50.2299 59.9400 39.0290 56.5600 15.78%
2023 58.5848 65.8478 68.4547 46.1552 48.8495 -25.49%
2022 65.6434 54.6809 73.9307 54.6809 65.5653 19.00%
2021 55.0101 52.9891 60.7434 47.3907 55.0962 2.89%
2020 51.3669 53.0089 56.4318 38.8319 53.5503 0.39%
2019 41.1920 42.0787 53.3413 35.2498 53.3413 27.86%
2018 45.8925 47.9247 54.2695 39.1333 41.7175 -12.91%
2017 44.5656 45.2381 51.0827 35.8623 47.9013 7.72%
2016 47.6300 50.0924 58.0153 37.4613 44.4695 -13.50%
2015 47.5487 43.4640 52.5552 42.3237 51.4076 19.24%
2014 37.5034 37.1326 44.4942 33.3285 43.1135 14.18%
2013 30.6149 22.5371 37.9906 22.5371 37.7577 69.95%
2012 22.3583 22.9395 24.3964 21.0032 22.2167 -3.78%
2011 18.6682 16.6231 23.1229 15.8140 23.0902 39.43%
2010 15.7608 15.4582 17.2656 13.6961 16.5606 8.74%
2009 12.6818 13.6279 15.4640 9.9926 15.2290 14.78%
2008 11.9186 14.0798 14.5917 9.7182 13.2683 -6.05%
2007 15.1323 13.6564 16.9555 13.5114 14.1224 4.75%
2006 12.1494 11.3694 13.4822 10.2512 13.4822 19.92%
2005 11.6456 11.8911 12.6592 10.2882 11.2422 -6.16%
2004 11.5572 13.2584 13.8411 10.3990 11.9799 -7.27%
2003 11.1184 10.3940 12.9196 9.1396 12.9196 29.02%
2002 12.9686 21.0718 21.2583 8.6774 10.0133 -52.36%
2001 23.4518 28.9150 28.9150 20.1940 21.0182 -29.71%
2000 23.3832 25.6336 29.9018 17.3758 29.9018 17.11%
1999 26.9738 25.6032 31.0037 22.7050 25.5341 -2.80%
1998 21.2220 18.3803 26.2707 17.4441 26.2707 42.93%
1997 14.6536 10.1994 18.9204 10.1994 18.3803 77.07%
1996 8.6040 7.8319 10.9468 7.4224 10.3804 32.15%
1995 6.2111 5.2242 7.8777 5.1471 7.8548 53.26%
1994 4.7950 4.8289 5.3007 4.3118 5.1250 6.09%
1993 4.7590 5.3048 5.3048 4.1875 4.8306 -9.48%
1992 5.5898 6.7688 6.8071 4.8654 5.3364 -21.16%
1991 5.9725 4.9556 6.7688 4.5651 6.7688 35.84%
1990 4.2999 4.0722 4.9940 3.6595 4.9831 24.56%
1989 3.4629 3.0448 4.0432 3.0187 4.0007 28.87%
1988 2.8911 2.9348 3.1214 2.6125 3.1044 9.89%
1987 3.2364 2.8625 3.7321 2.4768 2.8249 0.77%
1986 2.5679 2.2308 2.9813 2.0486 2.8032 24.71%
1985 1.9884 1.7388 2.2942 1.6879 2.2478 26.48%
1984 1.5740 1.4633 1.7812 1.4165 1.7772 23.98%
1983 1.3173 1.1366 1.6160 1.0687 1.4335 25.66%
1982 1.0083 0.8949 1.2426 0.8674 1.1408 26.57%
1981 0.8880 0.8652 0.9924 0.7826 0.9013 5.45%
1980 0.6907 0.6172 0.8716 0.5216 0.8547 36.16%
1979 0.5862 0.6043 0.6489 0.5301 0.6277 3.50%
1978 0.5713 0.5663 0.6743 0.4792 0.6065 6.31%
1977 0.5526 0.5768 0.6043 0.4898 0.5705 -1.99%
1976 0.6202 0.5874 0.7019 0.5248 0.5821 -0.36%
1975 0.5267 0.4336 0.6245 0.3997 0.5842 37.39%
1974 0.3941 0.3965 0.4761 0.2682 0.4252 8.11%
1973 0.5187 0.5810 0.6055 0.3732 0.3933 -32.80%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $113.233B $45.006B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.957B 13.64
Gilead Sciences (GILD) United States $112.014B 20.29
Vertex Pharmaceuticals (VRTX) United States $105.474B 0.00
CSL (CSLLY) Australia $84.378B 0.00
Regeneron Pharmaceuticals (REGN) United States $76.580B 17.43
GSK (GSK) United Kingdom $68.581B 7.94
Argenex SE (ARGX) Netherlands $39.617B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.695B 0.00
BioNTech SE (BNTX) Germany $29.452B 0.00
Biogen (BIIB) United States $21.686B 9.31
Illumina (ILMN) United States $21.679B 79.01
BeiGene (ONC) Cayman Islands $17.250B 0.00
Moderna (MRNA) United States $16.259B 0.00
Genmab (GNMSF) Denmark $14.669B 17.59
Genmab (GMAB) Denmark $14.658B 21.50
Incyte (INCY) United States $13.590B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.841B 29.81
Sarepta Therapeutics (SRPT) United States $11.920B 107.58
Insmed (INSM) United States $11.673B 0.00
Bio-Techne Corp (TECH) United States $11.648B 44.98
Exact Sciences (EXAS) United States $10.457B 0.00
Exelixis (EXEL) United States $10.287B 23.39
QIAGEN (QGEN) Netherlands $10.196B 20.98
Vaxcyte (PCVX) United States $10.106B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $10.075B 41.62
Intra-Cellular Therapies (ITCI) United States $10.058B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.547B 32.45
Repligen (RGEN) United States $8.676B 113.04
Ascendis Pharma (ASND) Denmark $7.840B 0.00
Roivant Sciences (ROIV) United Kingdom $7.738B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.340B 7.18
Revolution Medicines (RVMD) United States $7.028B 0.00
Halozyme Therapeutics (HALO) United States $6.718B 15.17
Legend Biotech (LEGN) United States $6.140B 0.00
Blueprint Medicines (BPMC) United States $5.554B 0.00
Cytokinetics (CYTK) United States $5.502B 0.00
Nuvalent (NUVL) United States $5.443B 0.00
Telix Pharmaceuticals (TLX) Australia $4.897B 0.00
Alkermes (ALKS) Ireland $4.543B 15.26
Guardant Health (GH) United States $4.535B 0.00
TG Therapeutics (TGTX) United States $4.496B 0.00
Krystal Biotech (KRYS) United States $4.398B 72.82
ADMA Biologics Inc (ADMA) United States $4.387B 46.40
Viking Therapeutics (VKTX) United States $4.381B 0.00
Alvotech (ALVO) Luxembourg $4.076B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.885B 0.00
Axsome Therapeutics (AXSM) United States $3.879B 0.00
Scholar Rock Holding (SRRK) United States $3.790B 0.00
Arcellx (ACLX) United States $3.736B 0.00
Biohaven (BHVN) United States $3.713B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.672B 0.00
Avidity Biosciences (RNA) United States $3.515B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.452B 0.00
Immunovant (IMVT) United States $3.447B 0.00
Apellis Pharmaceuticals (APLS) United States $3.413B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.388B 0.00
SpringWorks Therapeutics (SWTX) United States $3.199B 0.00
Merus (MRUS) Netherlands $3.002B 0.00
NovoCure (NVCR) Jersey $2.970B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.960B 0.00
Vericel (VCEL) United States $2.937B 991.67
Xenon Pharmaceuticals (XENE) Canada $2.928B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.872B 22.13
Zai Lab (ZLAB) China $2.769B 0.00
Denali Therapeutics (DNLI) United States $2.749B 0.00
Amicus Therapeutics (FOLD) United States $2.695B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.620B 0.00
Twist Bioscience (TWST) United States $2.588B 0.00
Kymera Therapeutics (KYMR) United States $2.472B 0.00
Janux Therapeutics (JANX) United States $2.454B 0.00
Vera Therapeutics (VERA) United States $2.344B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.301B 0.00
CG Oncology (CGON) United States $2.296B 0.00
Edgewise Therapeutics (EWTX) United States $2.287B 0.00
Beam Therapeutics (BEAM) United States $2.185B 0.00
Protagonist Therapeutics (PTGX) United States $2.182B 13.76
Bavarian Nordic (BVNRY) Denmark $2.175B 13.33
IDEAYA Biosciences (IDYA) United States $2.077B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.014B 0.00
Ligand Pharmaceuticals (LGND) United States $2.008B 50.13
Mirum Pharmaceuticals (MIRM) United States $1.984B 0.00
Mesoblast (MESO) Australia $1.970B 0.00
Agios Pharmaceuticals (AGIO) United States $1.963B 0.00
Iovance Biotherapeutics (IOVA) United States $1.951B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.931B 16.05
Geron (GERN) United States $1.916B 0.00
NeoGenomics (NEO) United States $1.896B 0.00
Apogee Therapeutics (APGE) United States $1.848B 0.00
Disc Medicine (IRON) United States $1.763B 0.00
WAVE Life Sciences (WVE) Singapore $1.760B 0.00
Akero Therapeutics (AKRO) United States $1.734B 0.00
Belite Bio (BLTE) United States $1.713B 0.00
Certara (CERT) United States $1.708B 48.23
Galapagos (GLPG) Belgium $1.690B 0.00
ImmunityBio (IBRX) United States $1.686B 0.00
MannKind (MNKD) United States $1.679B 43.50
Vir Biotechnology (VIR) United States $1.666B 0.00
Dynavax Technologies (DVAX) United States $1.660B 97.15
Fortrea Holdings (FTRE) United States $1.632B 51.97
Arcutis Biotherapeutics (ARQT) United States $1.616B 0.00
Celldex Therapeutics (CLDX) United States $1.615B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.521B 0.00
Novavax (NVAX) United States $1.492B 0.00
Structure Therapeutics (GPCR) United States $1.446B 0.00
Viridian Therapeutics (VRDN) United States $1.442B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.439B 0.00
Travere Therapeutics (TVTX) United States $1.412B 0.00
Myriad Genetics (MYGN) United States $1.350B 0.00
Arcus Biosciences (RCUS) United States $1.299B 0.00
Nurix Therapeutics (NRIX) United States $1.292B 0.00
Arvinas (ARVN) United States $1.279B 0.00
MiMedx (MDXG) United States $1.271B 33.27
Day One Biopharmaceuticals (DAWN) United States $1.190B 0.00
Praxis Precision Medicines (PRAX) United States $1.177B 0.00
ANI Pharmaceuticals (ANIP) United States $1.157B 15.77
Spyre Therapeutics (SYRE) United States $1.155B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.119B 0.00
Intellia Therapeutics (NTLA) United States $1.039B 0.00
Liquidia Technologies (LQDA) United States $1.032B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.015B 0.00
Adaptive Biotechnologies (ADPT) United States $0.959B 0.00
Pacira BioSciences (PCRX) United States $0.953B 8.97
Anavex Life Sciences (AVXL) United States $0.952B 0.00
CureVac (CVAC) Germany $0.943B 7.65
Nuvation Bio (NUVB) United States $0.936B 0.00
Gyre Therapeutics (GYRE) United States $0.934B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.919B 0.00
Zymeworks (ZYME) United States $0.911B 0.00
Cytek Biosciences (CTKB) United States $0.878B 0.00
Cogent Biosciences (COGT) United States $0.866B 0.00
AbCellera Biologics (ABCL) Canada $0.862B 0.00
Oculis Holding AG (OCS) Switzerland $0.857B 0.00
Castle Biosciences (CSTL) United States $0.847B 151.25
ArriVent BioPharma (AVBP) United States $0.838B 0.00
Sana Biotechnology (SANA) United States $0.817B 0.00
Septerna (SEPN) United States $0.799B 0.00
Avid Bioservices (CDMO) United States $0.794B 0.00
Bicara Therapeutics (BCAX) United States $0.783B 0.00
Tyra Biosciences (TYRA) United States $0.769B 0.00
Immatics (IMTX) Germany $0.767B 0.00
Replimune (REPL) United States $0.757B 0.00
Upstream Bio (UPB) United States $0.734B 0.00
Pliant Therapeutics (PLRX) United States $0.731B 0.00
Dianthus Therapeutics (DNTH) United States $0.716B 0.00
Prothena (PRTA) Ireland $0.702B 0.00
89BIO (ETNB) United States $0.691B 0.00
CorMedix Inc (CRMD) United States $0.679B 0.00
UniQure (QURE) Netherlands $0.675B 0.00
Erasca (ERAS) United States $0.669B 0.00
Immunome (IMNM) United States $0.662B 0.00
Pharming Group (PHAR) Netherlands $0.659B 0.00
Cullinan Therapeutics (CGEM) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
LENZ Therapeutics (LENZ) United States $0.638B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.628B 0.00
Arbutus Biopharma (ABUS) United States $0.623B 0.00
CARGO Therapeutics (CRGX) United States $0.621B 0.00
GRAIL (GRAL) United States $0.596B 0.00
Tectonic Therapeutic (TECX) United States $0.592B 0.00
Keros Therapeutics (KROS) United States $0.590B 0.00
Humacyte (HUMA) United States $0.580B 0.00
Kura Oncology (KURA) United States $0.569B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.569B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.562B 0.00
Oric Pharmaceuticals (ORIC) United States $0.562B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.551B 0.00
Entrada Therapeutics (TRDA) United States $0.548B 9.21
Rapport Therapeutics (RAPP) United States $0.542B 0.00
Emergent Biosolutions (EBS) United States $0.535B 0.00
Annexon (ANNX) United States $0.515B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.508B 0.00
Mineralys Therapeutics (MLYS) United States $0.491B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.487B 0.00
MeiraGTx Holdings (MGTX) United States $0.485B 0.00
Opthea (OPT) Australia $0.480B 0.00
Stoke Therapeutics (STOK) United States $0.477B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.475B 0.00
MaxCyte (MXCT) United States $0.465B 0.00
MBX Biosciences (MBX) United States $0.457B 0.00
GH Research (GHRS) Ireland $0.446B 0.00
Celcuity (CELC) United States $0.443B 0.00
Kodiak Sciences (KOD) United States $0.438B 0.00
AnaptysBio (ANAB) United States $0.432B 0.00
Allogene Therapeutics (ALLO) United States $0.431B 0.00
Alpha Teknova (TKNO) United States $0.430B 0.00
Cartesian Therapeutics (RNAC) United States $0.428B 0.00
Kamada (KMDA) Israel $0.426B 26.46
Terns Pharmaceuticals (TERN) United States $0.426B 0.00
PureTech Health (PRTC) United States $0.421B 0.00
Astria Therapeutics (ATXS) United States $0.420B 0.00
Abivax SA (ABVX) France $0.404B 0.00
ChromaDex (CDXC) United States $0.403B 527.00
Prime Medicine (PRME) United States $0.386B 0.00
Aura Biosciences (AURA) United States $0.380B 0.00
Third Harmonic Bio (THRD) United States $0.376B 0.00
REGENXBIO (RGNX) United States $0.372B 0.00
Codexis (CDXS) United States $0.357B 0.00
Neumora Therapeutics (NMRA) United States $0.357B 0.00
Northwest Biotherapeutics (NWBO) United States $0.354B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.350B 0.00
Eton Pharmaceuticals (ETON) United States $0.350B 0.00
Precigen (PGEN) United States $0.344B 0.00
Contineum Therapeutics (CTNM) United States $0.343B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.342B 0.00
Sage Therapeutics (SAGE) United States $0.340B 0.00
Zenas BioPharma (ZBIO) United States $0.339B 0.00
Revance Therapeutics (RVNC) United States $0.339B 0.00
EnGene Holdings (ENGN) Canada $0.336B 0.00
Alumis (ALMS) United States $0.331B 0.00
Absci (ABSI) United States $0.328B 0.00
Tango Therapeutics (TNGX) United States $0.314B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.309B 0.00
Voyager Therapeutics (VYGR) United States $0.298B 7.68
XOMA Royalty (XOMA) United States $0.297B 0.00
ATyr Pharma (ATYR) United States $0.296B 0.00
Trevi Therapeutics (TRVI) United States $0.294B 0.00
Prima BioMed (IMMP) Australia $0.293B 0.00
Chimerix (CMRX) United States $0.292B 0.00
Neurogene (NGNE) United States $0.291B 0.00
Olema Pharmaceuticals (OLMA) United States $0.289B 0.00
Rezolute (RZLT) United States $0.284B 0.00
ITeos Therapeutics (ITOS) United States $0.284B 0.00
Atea Pharmaceuticals (AVIR) United States $0.276B 0.00
AC Immune (ACIU) Switzerland $0.269B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.268B 0.00
Candel Therapeutics (CADL) United States $0.266B 0.00
C4 Therapeutics (CCCC) United States $0.259B 0.00
Design Therapeutics (DSGN) United States $0.256B 0.00
Benitec Biopharma (BNTC) United States $0.255B 0.00
Verastem (VSTM) United States $0.255B 0.00
Semper Paratus Acquisition (TVGN) United States $0.254B 0.00
BioStem Technologies (BSEM) $0.250B 22.06
Compass Therapeutics (CMPX) United States $0.244B 0.00
Sangamo Therapeutics (SGMO) United States $0.243B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.241B 0.00
Urogen Pharma (URGN) United States $0.240B 0.00
Foghorn Therapeutics (FHTX) United States $0.239B 0.00
Fulcrum Therapeutics (FULC) United States $0.236B 0.00
Lifecore Biomedical (LFCR) United States $0.233B 0.00
Ocugen (OCGN) United States $0.229B 0.00
Anika Therapeutics (ANIK) United States $0.228B 0.00
Artiva Biotherapeutics (ARTV) United States $0.227B 0.00
Amarin (AMRN) Ireland $0.227B 0.00
DiaMedica Therapeutics (DMAC) United States $0.225B 0.00
Nautilus Biotechnology (NAUT) United States $0.221B 0.00
Gossamer Bio (GOSS) United States $0.220B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.208B 0.00
ACELYRIN, INC (SLRN) United States $0.207B 0.00
Inhibrx Biosciences (INBX) United States $0.206B 0.00
TuHURA Biosciences (HURA) United States $0.205B 0.00
Molecular Partners AG (MOLN) Switzerland $0.201B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.198B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.196B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.189B 0.00
Cardiff Oncology (CRDF) United States $0.185B 0.00
Adocia (ADOCY) France $0.183B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.182B 0.00
GENFIT S.A (GNFT) France $0.180B 0.00
BioAge Labs (BIOA) United States $0.177B 0.00
Alector (ALEC) United States $0.176B 0.00
Bright Minds Biosciences (DRUG) United States $0.172B 0.00
ScPharmaceuticals (SCPH) United States $0.170B 0.00
Coherus BioSciences (CHRS) United States $0.169B 0.00
Cidara Therapeutics (CDTX) United States $0.169B 0.00
Fate Therapeutics (FATE) United States $0.167B 0.00
Nkarta (NKTX) United States $0.166B 0.00
Greenwich LifeSciences (GLSI) United States $0.163B 0.00
Adherex Technologies (FENC) United States $0.163B 0.00
Puma Biotechnology (PBYI) United States $0.162B 6.90
Actuate Therapeutics (ACTU) United States $0.162B 0.00
Sagimet Biosciences (SGMT) United States $0.159B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.159B 0.00
Checkpoint Therapeutics (CKPT) United States $0.154B 0.00
Sutro Biopharma (STRO) United States $0.153B 0.00
Akoya Biosciences (AKYA) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.149B 0.00
Caribou Biosciences (CRBU) United States $0.149B 0.00
TScan Therapeutics (TCRX) United States $0.148B 0.00
Ventyx Biosciences (VTYX) United States $0.147B 0.00
Solid Biosciences (SLDB) United States $0.147B 0.00
Innate Pharma S.A (IPHA) France $0.147B 0.00
Compugen (CGEN) Israel $0.146B 82.00
Biomea Fusion (BMEA) United States $0.144B 0.00
Seres Therapeutics (MCRB) United States $0.144B 0.00
Seer (SEER) United States $0.142B 0.00
Zura Bio (ZURA) United States $0.141B 0.00
Climb Bio (CLYM) United States $0.134B 0.00
Monopar Therapeutics (MNPR) United States $0.134B 0.00
InflaRx (IFRX) Germany $0.131B 0.00
Instil Bio (TIL) United States $0.130B 0.00
2seventy Bio (TSVT) United States $0.128B 0.00
Inozyme Pharma (INZY) United States $0.128B 0.00
Renovaro (RENB) United States $0.126B 0.00
IGM Biosciences (IGMS) United States $0.124B 0.00
INmune Bio (INMB) United States $0.122B 0.00
Aligos Therapeutics (ALGS) United States $0.121B 0.00
XBiotech (XBIT) United States $0.118B 0.00
Alto Neuroscience (ANRO) United States $0.117B 0.00
Leap Therapeutics (LPTX) United States $0.117B 0.00
Tenaya Therapeutics (TNYA) United States $0.116B 0.00
Inventiva S.A (IVA) France $0.114B 0.00
Elutia (ELUT) United States $0.113B 0.00
Nuvectis Pharma (NVCT) United States $0.112B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.111B 0.00
TELA Bio (TELA) United States $0.111B 0.00
Black Diamond Therapeutics (BDTX) United States $0.109B 0.00
Vor Biopharma (VOR) $0.107B 0.00
Jasper Therapeutics (JSPR) United States $0.106B 0.00
Editas Medicine (EDIT) United States $0.104B 0.00
Cellectis S.A (CLLS) France $0.103B 0.00
DBV Technologies S.A (DBVT) France $0.102B 0.00
HilleVax (HLVX) United States $0.102B 0.00
Cabaletta Bio (CABA) United States $0.101B 0.00
23andMe Holding (ME) United States $0.100B 0.00
BioHarvest Sciences (BHST) Canada $0.100B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.099B 0.00
X4 Pharmaceuticals (XFOR) United States $0.097B 0.00
PepGen (PEPG) United States $0.097B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
MediciNova (MNOV) United States $0.096B 0.00
Cue Biopharma (CUE) United States $0.096B 0.00
Alpha Cognition (ACOG) Canada $0.095B 0.00
Immunic (IMUX) United States $0.095B 0.00
ALX Oncology Holdings (ALXO) United States $0.093B 0.00
Atara Biotherapeutics (ATRA) United States $0.090B 0.00
Genelux (GNLX) United States $0.089B 0.00
Mersana Therapeutics (MRSN) United States $0.089B 0.00
Adverum Biotechnologies (ADVM) United States $0.089B 0.00
Aadi Bioscience (AADI) United States $0.089B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.089B 0.00
Entera Bio (ENTX) Israel $0.088B 0.00
Scilex Holding (SCLX) United States $0.087B 0.00
Genenta Science S.p.A (GNTA) Italy $0.087B 0.00
Allakos (ALLK) United States $0.087B 0.00
Theratechnologies (THTX) Canada $0.086B 0.00
Adagene (ADAG) China $0.086B 0.00
I-Mab (IMAB) China $0.086B 0.00
Skye Bioscience (SKYE) United States $0.084B 0.00
VistaGen Therapeutics (VTGN) United States $0.083B 0.00
Citius Oncology (CTOR) United States $0.082B 0.00
Bluebird Bio (BLUE) United States $0.082B 0.00
BGM Group (BGM) China $0.082B 0.00
CAMP4 Therapeutics (CAMP) United States $0.082B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.082B 0.00
Applied Therapeutics (APLT) United States $0.079B 0.00
Quince Therapeutics (QNCX) United States $0.079B 0.00
Adicet Bio (ACET) United States $0.076B 0.00
Ikena Oncology (IKNA) United States $0.075B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
Aerovate Therapeutics (AVTE) United States $0.074B 0.00
Adlai Nortye (ANL) Cayman Islands $0.073B 0.00
Vigil Neuroscience (VIGL) United States $0.073B 0.00
Agenus (AGEN) United States $0.073B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.072B 0.00
Rani Therapeutics Holdings (RANI) United States $0.072B 0.00
Invizyne Technologies (IZTC) United States $0.071B 0.00
Abpro Holdings (ABP) United States $0.070B 0.00
Oncolytics Biotech (ONCY) Canada $0.070B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
CytomX Therapeutics (CTMX) United States $0.069B 5.18
Annovis Bio (ANVS) United States $0.067B 0.00
Galena Biopharma (SLS) United States $0.067B 0.00
Elicio Therapeutics (ELTX) United States $0.066B 0.00
FibroBiologics (FBLG) United States $0.066B 0.00
BeyondSpring (BYSI) United States $0.065B 0.00
Immuneering (IMRX) United States $0.064B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.063B 0.00
Generation Bio (GBIO) United States $0.062B 0.00
Werewolf Therapeutics (HOWL) United States $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.059B 0.00
Repare Therapeutics (RPTX) Canada $0.059B 0.00
Ovid Therapeutics (OVID) United States $0.058B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.058B 0.00
IO Biotech (IOBT) Denmark $0.057B 0.00
Shattuck Labs (STTK) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.056B 0.00
Invivyd (IVVD) United States $0.054B 0.00
Boundless Bio (BOLD) United States $0.054B 0.00
Spero Therapeutics (SPRO) United States $0.053B 14.00
PDS Biotechnology (PDSB) United States $0.053B 0.00
Inovio Pharmaceuticals (INO) United States $0.052B 0.00
Dyadic (DYAI) United States $0.049B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.049B 0.00
Xilio Therapeutics (XLO) United States $0.048B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.048B 0.00
Kezar Life Sciences (KZR) United States $0.048B 0.00
Celularity (CELU) United States $0.047B 0.00
Rapt Therapeutics (RAPT) United States $0.046B 0.00
Aileron Therapeutics (ALRN) United States $0.046B 0.00
Opus Genetics (IRD) United States $0.045B 0.00
VTv Therapeutics (VTVT) United States $0.044B 0.00
Precision BioSciences (DTIL) United States $0.044B 0.00
Clene (CLNN) United States $0.043B 0.00
Estrella Immunopharma (ESLA) United States $0.043B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Lantern Pharma (LTRN) United States $0.042B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.041B 0.00
Passage Bio (PASG) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Q32 Bio (QTTB) United States $0.041B 0.00
Omega Therapeutics (OMGA) United States $0.039B 0.00
Rallybio (RLYB) United States $0.039B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.038B 0.00
Lexaria Bioscience (LEXX) Canada $0.038B 0.00
AN2 Therapeutics (ANTX) United States $0.037B 0.00
Enzo Biochem (ENZ) United States $0.036B 0.00
SAB Biotherapeutics (SABS) United States $0.035B 0.00
Promis Neurosciences (PMN) Canada $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.032B 0.00
RenovoRx (RNXT) United States $0.032B 0.00
Cognition Therapeutics (CGTX) United States $0.032B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Lisata Therapeutics (LSTA) United States $0.031B 0.00
Chemomab Therapeutics (CMMB) Israel $0.030B 0.00
Medicus Pharma (MDCX) Canada $0.030B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.030B 0.00
UNITY Biotechnology (UBX) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
Curis (CRIS) United States $0.029B 0.00
LakeShore Biopharma (LSB) China $0.029B 0.00
Beyond Air (XAIR) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.027B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
HOOKIPA Pharma (HOOK) United States $0.026B 0.00
BioAtla (BCAB) United States $0.026B 0.00
OnKure Therapeutics (OKUR) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Exicure (XCUR) United States $0.025B 0.00
Prana Biotechnology (ATHE) Australia $0.024B 0.00
Pluri (PLUR) Israel $0.024B 0.00
IN8bio (INAB) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Gelteq (GELS) Australia $0.022B 0.00
NextCure (NXTC) United States $0.022B 0.00
Ocean Biomedical (OCEA) United States $0.022B 0.00
Pulmatrix (PULM) United States $0.022B 0.00
Athira Pharma (ATHA) United States $0.022B 0.00
Cara Therapeutics (CARA) United States $0.022B 0.00
Tenax Therapeutics (TENX) United States $0.021B 0.00
GeoVax Labs (GOVX) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Bolt Biotherapeutics (BOLT) United States $0.021B 0.00
Aprea Therapeutics (APRE) United States $0.020B 0.00
Affimed (AFMD) Germany $0.019B 0.00
BioXcel Therapeutics (BTAI) United States $0.019B 0.00
Palvella Therapeutics (PVLA) United States $0.018B 0.00
Senti Biosciences (SNTI) United States $0.018B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
BRIACELL THERAP (BCTX) Canada $0.018B 0.00
MetaVia (MTVA) United States $0.018B 0.00
NKGen Biotech (NKGN) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Spruce Biosciences (SPRB) United States $0.015B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.014B 0.00
Aptose Biosciences (APTO) Canada $0.013B 0.00
Hoth Therapeutics (HOTH) United States $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
CervoMed (CRVO) United States $0.013B 0.00
Sensei Biotherapeutics (SNSE) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.013B 0.00
BioAffinity Technologies (BIAF) United States $0.013B 0.00
Mustang Bio (MBIO) United States $0.012B 0.00
Eyenovia (EYEN) United States $0.012B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.012B 0.00
Apollomics (APLM) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.011B 0.00
Carmell (CTCX) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Mainz Biomed (MYNZ) Germany $0.009B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Silo Pharma (SILO) United States $0.008B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.008B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
GENPREX (GNPX) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.006B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Palisade Bio (PALI) United States $0.005B 0.00
Moleculin Biotech (MBRX) United States $0.005B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.005B 0.00
Purple Biotech (PPBT) Israel $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.001B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00